These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35248291)

  • 21. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
    Ryll U; Bastiaenen C; De Bie R; Staal B
    Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.
    Jones S; Man WD; Gao W; Higginson IJ; Wilcock A; Maddocks M
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009419. PubMed ID: 27748503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for managing skeletal muscle spasticity following traumatic brain injury.
    Synnot A; Chau M; Pitt V; O'Connor D; Gruen RL; Wasiak J; Clavisi O; Pattuwage L; Phillips K
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008929. PubMed ID: 29165784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity.
    Gupta AD; Chu WH; Howell S; Chakraborty S; Koblar S; Visvanathan R; Cameron I; Wilson D
    Syst Rev; 2018 Jan; 7(1):1. PubMed ID: 29304876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
    Albavera-Hernández C; Rodríguez JM; Idrovo AJ
    Clin Rehabil; 2009 May; 23(5):394-407. PubMed ID: 19389744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).
    Hoare BJ; Wallen MA; Imms C; Villanueva E; Rawicki HB; Carey L
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003469. PubMed ID: 20091546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Botulinum Toxin Type A in Children With Spastic Cerebral Palsy Aged <2 Years: A Systematic Review.
    Yang H; Chen S; Shen J; Chen Y; Lai M; Chen L; Fang S
    J Child Neurol; 2023 May; 38(6-7):454-465. PubMed ID: 37431191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.
    Blumetti FC; Belloti JC; Tamaoki MJ; Pinto JA
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD001408. PubMed ID: 31591703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of spasticity with botulinum toxin.
    O'Brien CF
    Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
    Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
    J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin and spasticity.
    Davis EC; Barnes MP
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):143-7. PubMed ID: 10896682
    [No Abstract]   [Full Text] [Related]  

  • 34. Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity.
    Mills PB; Finlayson H; Sudol M; O'Connor R
    Clin Rehabil; 2016 Jun; 30(6):537-48. PubMed ID: 26198891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise interventions for cerebral palsy.
    Ryan JM; Cassidy EE; Noorduyn SG; O'Connell NE
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011660. PubMed ID: 28602046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review.
    Intiso D; Santamato A; Di Rienzo F
    Disabil Rehabil; 2017 Oct; 39(21):2123-2133. PubMed ID: 27764971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral palsy and bruxism: Effects of botulinum toxin injections-A randomized controlled trial.
    Cahlin BJ; Lindberg C; Dahlström L
    Clin Exp Dent Res; 2019 Oct; 5(5):460-468. PubMed ID: 31687178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review.
    Koog YH; Min BI
    Clin Rehabil; 2010 Aug; 24(8):685-700. PubMed ID: 20554641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
    Hasnat MJ; Rice JE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome.
    Martimbianco ALC; Torloni MR; Andriolo BN; Porfírio GJ; Riera R
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011289. PubMed ID: 29231243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.